Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary (34) Apply Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Summaries of opinion Remove Summaries of opinion filter Withdrawn applications Remove Withdrawn applications filter Paediatric investigation plans Remove Paediatric investigation plans filter Orphan designations Remove Orphan designations filter Referrals Remove Referrals filter Direct healthcare professional communication (14) Apply Direct healthcare professional communication filter

Product number

Patient safety

Yes (1) Apply Yes filter

Authorisation status

Authorised (419) Apply Authorised filter Refused (16) Apply Refused filter Withdrawn (56) Apply Withdrawn filter

ATC code

Marketing authorisation date

From:

To:

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

From:

To:

Opinion status

Negative (2) Apply Negative filter Positive (17) Apply Positive filter

Application type

Initial authorisation (10) Apply Initial authorisation filter Post-authorisation (9) Apply Post-authorisation filter

Withdrawal type

Initial authorisation (68) Apply Initial authorisation filter Post-authorisation (4) Apply Post-authorisation filter

Withdrawal date

From:

To:

PIP decision type

P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) (9) Apply P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) filter PM: decision on the application for modification of an agreed PIP (82) Apply PM: decision on the application for modification of an agreed PIP filter W: decision granting a waiver in all age groups for all conditions or indications (19) Apply W: decision granting a waiver in all age groups for all conditions or indications filter

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

From:

To:

PIP compliance check

Yes (21) Apply Yes filter

Compliance procedure number

Orphan designation – intended use

Orphan decision number

Orphan designation status

Positive (246) Apply Positive filter Withdrawn (8) Apply Withdrawn filter

Referral name

Referral status

European Commission final decision (6) Apply European Commission final decision filter Procedure started (1) Apply Procedure started filter

Referral safety status

Yes (3) Apply Yes filter

Referral type

Article 20 procedures (4) Apply Article 20 procedures filter Article 31 referrals (3) Apply Article 31 referrals filter

Referral reference number

Referral decision making model

PRAC-CAT-CHMP-EC (1) Apply PRAC-CAT-CHMP-EC filter PRAC-CHMP-EC (4) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (3) Apply Centrally and nationally authorised products (mixed) filter Centrally authorised product(s) (4) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (3) Apply Risk minimisation measures filter Variation (1) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Medicine type

Accelerated assessment Remove Accelerated assessment filter Conditional approval Remove Conditional approval filter Generic Remove Generic filter Orphan medicine Remove Orphan medicine filter Additional monitoring (723) Apply Additional monitoring filter Biosimilar (98) Apply Biosimilar filter Exceptional circumstances (80) Apply Exceptional circumstances filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

954 results

Remove all filtersRemove all filters

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Orphan designations Remove Orphan designations filter Referrals Remove Referrals filter Withdrawn applications Remove Withdrawn applications filter Paediatric investigation plans Remove Paediatric investigation plans filter Summaries of opinion Remove Summaries of opinion filter

Categories Human Remove Human filter

Medicine type Accelerated assessment Remove Accelerated assessment filter Generic Remove Generic filter Conditional approval Remove Conditional approval filter Orphan medicine Remove Orphan medicine filter

Sort by

List item

Human medicine European public assessment report (EPAR): Idefirix (updated)

Imlifidase, Desensitization, Immunologic; Kidney Transplantation
Date of authorisation: 25/08/2020, , , , Revision: 3, Authorised, Last updated: 16/01/2023
List item

Human medicine European public assessment report (EPAR): Orphacol (updated)

cholic acid, Digestive System Diseases; Metabolism, Inborn Errors
Date of authorisation: 12/09/2013,
Date of refusal: 25/05/2012, , , , Revision: 12, Authorised, Last updated: 16/01/2023
List item

Human medicine European public assessment report (EPAR): Sugammadex Amomed (updated)

sugammadex sodium, Neuromuscular Blockade
Date of authorisation: 10/01/2023, , Authorised, Last updated: 13/01/2023
List item

Human medicine European public assessment report (EPAR): Pregabalin Mylan (updated)

pregabalin, Anxiety Disorders; Epilepsy
Date of authorisation: 24/06/2015, , Revision: 16, Authorised, Last updated: 13/01/2023
List item

Human medicine European public assessment report (EPAR): Ebvallo (updated)

Tabelecleucel, Lymphoproliferative Disorders
Date of authorisation: 16/12/2022, , , , Authorised, Last updated: 12/01/2023
List item

Human medicine European public assessment report (EPAR): Alofisel (updated)

darvadstrocel, Rectal Fistula
Date of authorisation: 23/03/2018, , , Revision: 9, Authorised, Last updated: 12/01/2023
List item

Human medicine European public assessment report (EPAR): Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen) (updated)

aripiprazole, Schizophrenia; Bipolar Disorder
Date of authorisation: 30/06/2015, , Revision: 15, Authorised, Last updated: 12/01/2023
List item

Human medicine European public assessment report (EPAR): Natpar (updated)

parathyroid hormone, Hypoparathyroidism
Date of authorisation: 24/04/2017, , , , Revision: 13, Authorised, Last updated: 11/01/2023
List item

Human medicine European public assessment report (EPAR): Tacforius (updated)

tacrolimus monohydrate, Liver Transplantation; Kidney Transplantation
Date of authorisation: 08/12/2017, , Revision: 7, Authorised, Last updated: 10/01/2023
List item

Human medicine European public assessment report (EPAR): Nuvaxovid (updated)

SARS-CoV-2 recombinant spike protein, COVID-19 virus infection
Date of authorisation: 20/12/2021, , , Revision: 7, Authorised, Last updated: 10/01/2023
List item

Human medicine European public assessment report (EPAR): Amvuttra (updated)

vutrisiran sodium, Amyloid Neuropathies, Familial
Date of authorisation: 15/09/2022, , , Revision: 1, Authorised, Last updated: 10/01/2023
List item

Human medicine European public assessment report (EPAR): Deferasirox Mylan (updated)

deferasirox, Iron Overload; beta-Thalassemia
Date of authorisation: 26/09/2019, , Revision: 8, Authorised, Last updated: 10/01/2023
List item

Human medicine European public assessment report (EPAR): Adakveo (updated)

Crizanlizumab, Anemia, Sickle Cell
Date of authorisation: 28/10/2020, , , , Revision: 3, Authorised, Last updated: 10/01/2023
List item

Human medicine European public assessment report (EPAR): Pregabalin Accord (updated)

pregabalin, Anxiety Disorders; Epilepsy
Date of authorisation: 28/08/2015, , Revision: 15, Authorised, Last updated: 09/01/2023
List item

Human medicine European public assessment report (EPAR): Pemazyre (updated)

pemigatinib, Cholangiocarcinoma
Date of authorisation: 26/03/2021, , , , Revision: 4, Authorised, Last updated: 09/01/2023
List item

Human medicine European public assessment report (EPAR): Pregabalin Sandoz GmbH (updated)

pregabalin, Anxiety Disorders; Epilepsy
Date of authorisation: 19/06/2015, , Revision: 14, Authorised, Last updated: 05/01/2023
List item

Human medicine European public assessment report (EPAR): Pregabalin Sandoz (updated)

pregabalin, Anxiety Disorders; Neuralgia; Epilepsy
Date of authorisation: 19/06/2015, , Revision: 15, Authorised, Last updated: 05/01/2023
List item

Human medicine European public assessment report (EPAR): Ibandronic acid Accord (updated)

ibandronic acid, Wounds and Injuries; Breast Diseases; Neoplastic Processes; Calcium Metabolism Disorders; Water-Electrolyte Imbalance
Date of authorisation: 18/11/2012, , Revision: 14, Authorised, Last updated: 05/01/2023
List item

Human medicine European public assessment report (EPAR): Ocaliva (updated)

Obeticholic acid, Liver Cirrhosis, Biliary
Date of authorisation: 12/12/2016, , , , Revision: 15, Authorised, Last updated: 04/01/2023
List item

Human medicine European public assessment report (EPAR): Posaconazole AHCL

posaconazole, Mycoses
Date of authorisation: 25/07/2019, , Revision: 5, Authorised, Last updated: 22/12/2022
List item

Human medicine European public assessment report (EPAR): Hepcludex

Bulevirtide acetate, Hepatitis D, Chronic
Date of authorisation: 31/07/2020, , , , Revision: 8, Authorised, Last updated: 22/12/2022
List item

Human medicine European public assessment report (EPAR): Opsumit

Macitentan, Hypertension, Pulmonary
Date of authorisation: 20/12/2013, , Revision: 21, Authorised, Last updated: 22/12/2022
List item

Human medicine European public assessment report (EPAR): Dimethyl fumarate Teva

dimethyl fumarate, Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis
Date of authorisation: 12/12/2022, , Authorised, Last updated: 21/12/2022
List item

Human medicine European public assessment report (EPAR): Abecma

idecabtagene vicleucel, Multiple Myeloma; Neoplasms; Cancer; Neoplasms, Plasma Cell; Hemostatic Disorders; Vascular Diseases; Cardiovascular Diseases; Paraproteinemias; Blood Protein Disorders; Hematologic Diseases; Hemic and Lymphatic Diseases; Hemorrhagic Disorders; Infectious Mononucleosis; Lymphoproliferative Disorders; Immunoproliferative Disorders; Immune System Diseases
Date of authorisation: 18/08/2021, , , , Revision: 5, Authorised, Last updated: 21/12/2022
List item

Human medicine European public assessment report (EPAR): Retsevmo

Selpercatinib, Carcinoma, Non-Small-Cell Lung; Thyroid Neoplasms
Date of authorisation: 11/02/2021, , , Revision: 5, Authorised, Last updated: 20/12/2022

Load more

954 results

Human medicine European public assessment report (EPAR): Idefirix (updated)

Human medicine European public assessment report (EPAR): Orphacol (updated)

Human medicine European public assessment report (EPAR): Sugammadex Amomed (updated)

Human medicine European public assessment report (EPAR): Pregabalin Mylan (updated)

Human medicine European public assessment report (EPAR): Ebvallo (updated)

Human medicine European public assessment report (EPAR): Alofisel (updated)

Human medicine European public assessment report (EPAR): Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen) (updated)

Human medicine European public assessment report (EPAR): Natpar (updated)

Human medicine European public assessment report (EPAR): Tacforius (updated)

Human medicine European public assessment report (EPAR): Nuvaxovid (updated)

Human medicine European public assessment report (EPAR): Amvuttra (updated)

Human medicine European public assessment report (EPAR): Deferasirox Mylan (updated)

Human medicine European public assessment report (EPAR): Adakveo (updated)

Human medicine European public assessment report (EPAR): Pregabalin Accord (updated)

Human medicine European public assessment report (EPAR): Pemazyre (updated)

Human medicine European public assessment report (EPAR): Pregabalin Sandoz GmbH (updated)

Human medicine European public assessment report (EPAR): Pregabalin Sandoz (updated)

Human medicine European public assessment report (EPAR): Ibandronic acid Accord (updated)

Human medicine European public assessment report (EPAR): Ocaliva (updated)

Human medicine European public assessment report (EPAR): Posaconazole AHCL

Human medicine European public assessment report (EPAR): Hepcludex

Human medicine European public assessment report (EPAR): Opsumit

Human medicine European public assessment report (EPAR): Dimethyl fumarate Teva

Human medicine European public assessment report (EPAR): Abecma

Human medicine European public assessment report (EPAR): Retsevmo